MOUNTAIN VIEW, Calif., April 29, 2025--(BUSINESS WIRE)--RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing innovative ...

This is higher than reported in most, if not all, previous studies." The PROHEAR Study is on track to complete enrollment by the end of the second half of 2025. For more information, visit ...

Medicare’s shift toward privatization could get a significant boost if the Centers for Medicare & Medicaid Services embraces ...

This is higher than reported in most, if not all, previous studies.” The PROHEAR Study is on track to complete enrollment by the end of the second half of 2025. For more information, visit ...

Patient flow forecasting is a fundamental tool in healthcare and pharmaceutical industries, enabling stakeholders to predict and plan for the treatment requirements of patients accurately.

The initiation of patient enrollment at Johns Hopkins Medicine will be at their Sibley Memorial Hospital campus and marks the most recent site to support RenovoRx’s path to completing patient ...

"Kalkine Media dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ...